Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00499616 · OUTCOME

Second-event-free Survival (E2FS)

Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young Patients With Neuroblastoma · Source last updated 2021-07-06

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage
Interval / dispersion
95% Confidence Interval
Time frame
From the time of the first progressive, non-metastatic event until the subsequent occurrence of relapse, progressive disease, secondary malignancy, or death; up to 3 years

What was measured

E2FS (from time of first event) will be calculated to describe the outcome for patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy.

Analysis population: Eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy

Groups in this outcome

All Patients

All eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
All Patients7

Reported measurements

Source class 1
Values in Percentage · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
All Patients57.14Not reported20.4993.79Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        20.49
        upper Limit
        93.79
        value
        57.14
denoms
  1. counts
    1. group Id
      OG000
      value
      7
    units
    Participants
description
E2FS (from time of first event) will be calculated to describe the outcome for patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy.
dispersion Type
95% Confidence Interval
groups
  1. description
    All eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy
    id
    OG000
    title
    All Patients
param Type
NUMBER
population Description
Eligible patients who have a first progressive, non-metastatic event during Observation and then receive protocol retrieval therapy
reporting Status
POSTED
time Frame
From the time of the first progressive, non-metastatic event until the subsequent occurrence of relapse, progressive disease, secondary malignancy, or death; up to 3 years
title
Second-event-free Survival (E2FS)
type
SECONDARY
unit Of Measure
Percentage

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice